Management of endometrial modifications in perimenopausal women

In: Medicine and Pharmacy Reports · 2015 · vol. 88(2) , pp. 101–110 · doi:10.15386/cjmed-421 · PMID:26528056 · W2039275362
review OA: bronze CC0 ⤵ 4 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-07

This paper outlines the management of endometrial modifications in perimenopausal women, emphasizing standardized classification and tailored treatments for abnormal uterine bleeding based on individual risk factors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This paper reviews how endometrial histopathology in perimenopausal women can range from nonproliferative or proliferative benign lesions to malignant lesions, often presenting clinically as abnormal uterine bleeding (AUB). It emphasizes that AUB management should use a standardized classification system and that treatment decisions should be tailored to factors including age, risk factors, symptoms, and cycle irregularities, with both medical and surgical options discussed at a high level. The authors also mention that alternative therapies and diet may improve long-term outcomes, while acknowledging the inherent variability in perimenopause and its hormone levels as a major caveat. This paper is centrally about endometriosis—relevant endometrial modifications and abnormal uterine bleeding during menopausal transition are discussed, but endometriosis is not explicitly addressed.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Perimenopause has a variable length and time of onset and is characterized by its variability in hormonal levels. The histological changes in the perimenopausal endometrium may be represented by nonproliferative or proliferative benign or malignant lesions. A commonly encountered manifestation of endometrium lesions during menopausal transition is the abnormal uterine bleeding (AUB). The clinical management of AUB must follow a standardized classification system for optimal results. The medical and surgical treatment must be adapted according to age, risk factors, symptoms, and cycle irregularities. Use of alternative therapies and proper diet may result in improved long-term outcomes.
Full text 1,365 characters · extracted from oa-doi-fallback · click to expand
Management of endometrial modifications in perimenopausal women DOI: https://doi.org/10.15386/cjmed-421Keywords: perimenopause, endometrium histopathology, clinical managementAbstract Perimenopause has a variable length and time of onset and is characterized by its variability in hormonal levels. The histological changes in the perimenopausal endometrium may be represented by nonproliferative or proliferative benign or malignant lesions. A commonly encountered manifestation of endometrium lesions during menopausal transition is the abnormal uterine bleeding (AUB). The clinical management of AUB must follow a standardized classification system for optimal results. The medical and surgical treatment must be adapted according to age, risk factors, symptoms, and cycle irregularities. Use of alternative therapies and proper diet may result in improved long-term outcomes. Downloads Published How to Cite Issue Section License The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder. The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK